CytoVale

cytovale.com

Cytovale is a medical technology company that has developed Intelli Sep, an FDA-cleared diagnostic tool for early sepsis detection. This innovative solution risk-stratifies patients based on their likelihood of developing sepsis within three days, providing results in approximately eight minutes. By analyzing the immune response through the biomechanical properties of white blood cells, Intelli Sep offers a highly sensitive measure for identifying sepsis, addressing a critical gap in timely diagnosis and treatment. The company aims to improve patient outcomes and operational efficiencies in emergency departments, positioning itself as a leader in sepsis diagnostics.